This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 Top Performing Stocks of the Best ETF of 1H2018
by Sweta Killa
Inside the top performing stocks of the top ETF of the first half of 2018.
RTI Surgical (RTIX) to Acquire Zyga, Improve Spine Surgeries
by Zacks Equity Research
RTI Surgical (RTIX) to integrate Zyga's SImmetry Sacroiliac Joint Fusion System to diversify Spine franchise.
FDA Nod for Zimmer Biomet's Sidus, Aids Arthroplasty Arm
by Zacks Equity Research
Zimmer Biomet's (ZBH) Sidus Stem-Free Shoulder system offers a minimal bone resection in total shoulder arthroplasty, which the company claims to help reduce pain and restore a range of motions.
Entellus (ENTL) Nears 52-Week High: What's Driving It?
by Zacks Equity Research
Entellus Medical Inc. (ENTL) gains from latest technology and promising revenue trends.
Is Tactile Systems Technology (TCMD) a Great Growth Stock?
by Zacks Equity Research
Tactile Systems Technology (TCMD) is seeing solid earnings estimate revision and has a favorable Zacks rank, making it well positioned for future earnings growth.
Cogentix (CGNT) Stock Near 52-Week High: More Room to Run?
by Zacks Equity Research
Cogentix Medical (CGNT) stock continues to hover around the 52-week high mark reached on Dec 27, courtesy of its new strategies.
Robust Pipeline Aids Edwards Lifesciences, Rising Costs Ail
by Zacks Equity Research
Edwards Lifesciences' (EW) pipeline building to fortify foothold across all operating businesses bodes well. Also, the TAVR adoption rate across Japan and the European countries is impressive.
Align Rides on Balanced Segmental Growth Amid Stiff Contest
by Zacks Equity Research
Align (ALGN) gains from balanced sales growth across all its channels of late, primarily on high InvisAlign Technology case volumes.
The Zacks Analyst Blog Highlights: Bio-Rad Laboratories, Mazor Robotics, Tactile Systems, Eli Lilly and DexCom
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Bio-Rad Laboratories, Mazor Robotics, Tactile Systems, Eli Lilly and DexCom
4 MedTech Stocks to Explode in 2018
by Zacks Equity Research
Standing at the threshold of 2018 it is imperative for the investors to find the means which can dilute the macroeconomic woes and help them gain more.
Increased Earnings Estimates Seen for Tactile Systems (TCMD): Can It Move Higher?
by Zacks Equity Research
Tactile Systems (TCMD) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision, along with decent short-term momentum.
Zacks.com featured highlights: Align Technology, SORL Auto Parts, Nova Measuring Instruments, WageWorks and Tactile Systems Technology
by Zacks Equity Research
Zacks.com featured highlights: Align Technology, SORL Auto Parts, Nova Measuring Instruments, WageWorks and Tactile Systems Technology
5 Best Profitable Stocks to Buy in December
by Zacks Equity Research
Net income ratio gives us the exact profit level of a company and reflects the percentage of net income to total sales revenues.
Top Ranked Momentum Stocks to Buy for August 31st
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 31st:
Can The Uptrend Continue for Tactile Systems Technology (TCMD)?
by Zacks Equity Research
Investors certainly have to be happy with Tactile Systems Technology Inc (TCMD) and its short term performance
Will Tactile Systems Technology (TCMD) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Tactile Systems Technology Inc (TCMD).
Tactile Systems Technology (TCMD) Shares March Higher, Can It Continue?
by Zacks Equity Research
Tactile Systems Technology, Inc. (TCMD) has been on the move lately as the stock has risen by 22.3% in the past four weeks, and it is currently trading well above its 20-Day SMA